Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 4, Pages e2740-e2740
Publisher
Springer Nature
Online
2017-04-07
DOI
10.1038/cddis.2017.158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An overview of microRNAs
- (2015) Scott M. Hammond ADVANCED DRUG DELIVERY REVIEWS
- Innate Immune Recognition of Cancer
- (2015) Seng-Ryong Woo et al. Annual Review of Immunology
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Distinct Mechanisms of Tumor Resistance to NK Killing: Of Mice and Men
- (2015) Drew M. Pardoll IMMUNITY
- Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells
- (2015) Shien Hu et al. Molecular Cancer
- MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer
- (2015) Hanbyoul Cho et al. BMC CANCER
- MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
- (2015) Paula Codo et al. Oncotarget
- Resistance to Cytarabine Induces the Up-regulation of NKG2D Ligands and Enhances Natural Killer Cell Lysis of Leukemic Cells
- (2015) Henry Ogbomo et al. NEOPLASIA
- Valproic Acid Upregulates NKG2D Ligand Expression through an ERK-dependent Mechanism and Potentially Enhances NK Cell-mediated Lysis of Myeloma
- (2015) Xiaosong Wu et al. NEOPLASIA
- Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells
- (2014) José E. Vargas et al. Biochemistry and Cell Biology
- Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway
- (2014) Pengfei Shi et al. BMC CANCER
- Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
- (2014) H Yang et al. BRITISH JOURNAL OF CANCER
- Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression
- (2014) Jingyan Xie et al. Cellular & Molecular Immunology
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma
- (2014) Liang Fang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
- (2013) Ming-Tsang Chiao et al. Autophagy
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer
- (2013) Esmerina Tili et al. IMMUNOLOGICAL REVIEWS
- NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study
- (2012) Esther M de Kruijf et al. BMC CANCER
- MiR-10b Downregulates the Stress-Induced Cell Surface Molecule MICB, a Critical Ligand for Cancer Cell Recognition by Natural Killer Cells
- (2012) P. Tsukerman et al. CANCER RESEARCH
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- miRNAs and cancer: An epigenetics view
- (2012) Marcos Malumbres MOLECULAR ASPECTS OF MEDICINE
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
- (2012) Davis J. McCarthy et al. NUCLEIC ACIDS RESEARCH
- The miR-17 Family Links p63 Protein to MAPK Signaling to Promote the Onset of Human Keratinocyte Differentiation
- (2012) Ning Wu et al. PLoS One
- Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer
- (2011) K Kim et al. ONCOGENE
- miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1
- (2010) Hongling Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer
- (2010) Xiaohui Duan et al. MEDICAL ONCOLOGY
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
- (2009) C. J. Chan et al. JOURNAL OF IMMUNOLOGY
- Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis
- (2008) Kui Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
- Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
- (2008) Noam Stern-Ginossar et al. NATURE IMMUNOLOGY
- Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
- (2008) A. M. Unni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NKG2D ligands: key targets of the immune response
- (2008) Segundo González et al. TRENDS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now